| Financial Year |
March 31 2023 |
| Monetary Funds |
14,381,998,113.82 |
| Held-for-trading Financial Assets |
5,235,068,519.92 |
| Notes Receivable |
262,685,866.52 |
| Accounts Receivable |
27,106,770,881.20 |
| Advances to Suppliers |
3,064,006,795.97 |
| Other Receivables |
869,045,448.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
19,571,761,548.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,731,196,020.17 |
| Other Current Assets |
2,868,903,682.06 |
| Total Current Assets |
78,743,226,253.98 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
18,212,240,802.43 |
| Long-term Equity Investment |
4,525,663,107.24 |
| Investment Properties |
160,191,350.57 |
| Fixed Assetes |
11,455,724,054.72 |
| Under-construction Projects |
2,850,294,913.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
5,452,145,323.05 |
| R&D expenses |
19,759,048.90 |
| Goodwill |
2,610,725,726.55 |
| Long-Term Deferred and Prepaid Expenses |
14,850,939.46 |
| Deferred Income Tax Assets |
1,910,196,429.24 |
| Other Non-Current Assets |
447,342,365.17 |
| Sub-Total of Non-Current Assets |
50,908,785,536.71 |
| Total Assets |
129,652,011,790.69 |
| Short-Term Loans |
7,910,535,359.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,144,261,927.39 |
| Accounts Payable |
13,131,867,256.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
412,807,292.17 |
| Taxes Payable |
347,476,249.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,672,965,593.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,720,703,158.85 |
| Other Current Liabilities |
6,708,542,045.77 |
| Sub-Total of Current Liabilities |
52,154,523,710.04 |
| Long-term Loans |
11,556,028,272.79 |
| Bonds Payable |
25,506,249.98 |
| Long-Term Accounts Payable |
570,453,802.86 |
| Special Payable |
-- |
| Estimatied Liabilities |
20,975,591.13 |
| Deferred Income Tax Liabilities |
843,748,237.49 |
| Other Non-Current Liabilities |
3,113,850,858.00 |
| Sub-Total of Non-Current Liabilities |
20,338,596,226.12 |
| Total Liabilities |
72,493,119,936.16 |
| Paid-In Capital(Or Share Stock) |
8,677,992,236.00 |
| Capital Surplus |
19,699,585,843.21 |
| Surplus Reserve |
4,384,443,521.49 |
| LESS:Treasury Stock |
2,641,002,729.02 |
| Undistributed Profits |
25,710,250,324.79 |
| Minority Stockholder's Interest |
2,566,116,456.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
54,592,775,398.15 |
| Owner's Equity（Stockholder's Equity） |
57,158,891,854.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
129,652,011,790.69 |
